- Report
- January 2019
- 212 Pages
Global
From €21269EUR$22,000USD£18,269GBP
Actonel is a brand name for the drug risedronate, a bisphosphonate used to treat and prevent osteoporosis in postmenopausal women. It is also used to treat Paget's disease of bone and to prevent and treat glucocorticoid-induced osteoporosis. Actonel belongs to the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat endocrine and metabolic disorders such as diabetes, thyroid disorders, and obesity. These drugs are used to regulate hormones, metabolism, and other body functions.
The Endocrine and Metabolic Disorders Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Takeda. Show Less Read more